RedHill Biopharma has received allowances for U.S. patent applications covering Opaganib and RHB-107 for COVID-19
The two patents protect opaganib and RHB-107 for the treatment of COVID-19 until at least 2041 once granted
The two patents protect opaganib and RHB-107 for the treatment of COVID-19 until at least 2041 once granted
New design is half the thickness of previous models
Why choosing the right dosing pump can be critical to the formulation of lipid nanoparticles (LNPs) and the rapid rollout of mRNA-based vaccines
Dr. Boye Schnack Nielsen shares tips for running successful in situ hybridization assays as he provides insights on how RNA detection methods have evolved over time
Explorer and scientist Ulyana Nadia Horodyskyj reveals how she reaches new heights in her work
The seamless integration of AI into digital pathology workflows aims to improve quality and efficiency of cancer diagnosis
The kit detects four hazardous Aspergillus species in cannabis flower
The antigen test is used to detect the nucleocapsid protein antigen in SARS-CoV-2
Lightblades spectrophotometers line are designed for use with CRAIC microscope spectrophotometers
m2p-labs, BioLector family of products acquired by Beckman Coulter Life Sciences in 2020
The sensor is seven times smaller and offers many more disruptive features
Find out how a pioneering precision medicine company is using cell counting technology to improve patient outcomes
Industry-leading 3D ligand-based design approaches from BioPharmics will be available in StarDrop, Optibrium’s small molecule design and optimization software